IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 175 filers reported holding IMMUNOMEDICS INC in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,732,000 | +27.4% | 105,318 | -51.5% | 0.06% | -20.0% |
| Q1 2020 | $2,929,000 | +260.7% | 217,303 | +254.7% | 0.08% | +971.4% |
| Q3 2019 | $812,000 | -67.7% | 61,264 | -53.2% | 0.01% | -74.1% |
| Q1 2019 | $2,513,000 | +217.7% | 130,813 | +136.0% | 0.03% | +200.0% |
| Q4 2018 | $791,000 | -47.5% | 55,430 | -23.4% | 0.01% | -50.0% |
| Q3 2018 | $1,508,000 | -3.5% | 72,400 | +9.6% | 0.02% | -14.3% |
| Q2 2018 | $1,563,000 | +177.1% | 66,050 | +71.0% | 0.02% | +133.3% |
| Q1 2018 | $564,000 | -6.5% | 38,625 | +3.5% | 0.01% | -18.2% |
| Q4 2017 | $603,000 | +64.8% | 37,304 | +42.5% | 0.01% | +57.1% |
| Q3 2017 | $366,000 | +171.1% | 26,180 | +71.3% | 0.01% | +133.3% |
| Q2 2017 | $135,000 | +3.8% | 15,280 | -56.9% | 0.00% | -40.0% |
| Q4 2016 | $130,000 | +209.5% | 35,471 | +176.6% | 0.01% | +66.7% |
| Q3 2016 | $42,000 | – | 12,825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
| Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
| Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
| Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
| Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
| NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
| RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
| DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
| Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
| DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |